Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dashamoola Kwatha is a traditional Ayurvedic polyherbal decoction composed of the roots of ten medicinal plants, collectively known as Dashamoola. It is widely utilized in Ayurvedic medicine for its potent anti-inflammatory, analgesic, and anti-rheumatic properties. The formulation is traditionally indicated for Vata-related disorders, including various neuromuscular conditions such as limb-girdle muscular dystrophy, as well as respiratory ailments and joint pain. Pharmacological studies have demonstrated that Dashamoola Kwatha exerts its therapeutic effects by down-regulating key pro-inflammatory mediators, including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 beta (IL-1β), and Interleukin-6 (IL-6), and by inhibiting the expression of inducible nitric oxide synthase (iNOS). It is commonly administered as an oral solution and is often used in conjunction with other Ayurvedic therapies like Panchakarma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dashamoola kwatha.